Medicare Enrolled
Dr. Tatiana Nagibina, M.D.
Rheumatology · Palm Harbor, FL
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Nagibina from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Nagibina?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Nagibina
Dr. Tatiana Nagibina is a rheumatology specialist in Palm Harbor, FL, with 20 years of NPI registration. Based on federal Medicare data, Dr. Nagibina performed 5,161 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Nagibina received a total of $25,340 from 50 pharmaceutical and/or device companies across 1423 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Nagibina is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years of NPI registration
▲ Top 50% volume in FL
$25,340 industry payments
Florida License Status
FL DOH · MQA1
Active license
None
Board action on record
0
Recent admin complaints
| Profession | License # | Status | Expires | Board Action |
|---|---|---|---|---|
| Medical Doctor | 81965 | Clear | January 31, 2028 | — |
Data from Florida Department of Health Medical Quality Assurance.
License records are public under Chapter 119, Florida Statutes.
Verify directly on FL DOH →
Medicare Practice Summary — 2023
Medicare Utilization ↗5,161
Medicare services
Top 50% in FL for rheumatology
Not available
Unique patients (not deduplicated)
$28
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Denosumab injection (Prolia/Xgeva) | 3,960 | $19 | $27 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
401 | $91 | $170 |
| Physical therapy exercise, per 15 min A therapy session using exercises to improve strength, endurance, range of motion, and flexibility. Each 15-minute unit is billed separately. |
236 | $19 | $60 |
| Manual therapy (hands-on treatment), per 15 min | 138 | $16 | $60 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
97 | $96 | $260 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
91 | $62 | $120 |
| Non-hormonal chemotherapy injection This procedure involves administering non-hormonal anti-neoplastic chemotherapy medication via injection into the skin or muscle tissue. |
90 | $54 | $140 |
| Bone density scan (DEXA) A test that uses low-dose X-rays to measure bone mineral density in the hip, pelvis, and spine. It helps assess bone strength and risk of fractures. |
41 | $36 | $100 |
| Wrist X-ray, minimum 3 views An imaging test using X-rays to capture at least three different angles of the wrist bones and joints. |
22 | $31 | $85 |
| X-ray of hand, minimum of 3 views An X-ray imaging test of the hand that captures at least three different angles to visualize the bones and joints. |
22 | $28 | $70 |
| Foot X-ray, 3+ views An X-ray imaging test of the foot that captures at least three different views to evaluate the bones and joints. |
22 | $22 | $85 |
| Chest X-ray, 2 views An X-ray imaging test of the chest that captures two different angles to visualize the lungs, heart, and chest wall. |
16 | $24 | $50 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
14 | $130 | $200 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
11 | $100 | $300 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
1.9% high complexity
78.5% medium
19.6% routine
Industry Payment Transparency
Open Payments through 2024 ↗$25,340
Total received (2018-2024)
Avg $3,620/year across 7 years
Top 18% in FL for rheumatology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
50
Companies
1,423
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$4,182
2023
$4,136
2022
$3,815
2021
$3,599
2020
$2,759
2019
$3,361
2018
$3,488
Payments by company (2024)
Amgen Inc.
$573
ABBVIE INC.
$491
GlaxoSmithKline, LLC.
$427
UCB, Inc.
$303
Mallinckrodt Hospital Products Inc.
$298
Novartis Pharmaceuticals Corporation
$268
E.R. Squibb & Sons, L.L.C.
$251
Janssen Biotech, Inc.
$236
Fresenius Kabi USA, LLC
$199
PFIZER INC.
$198
Lilly USA, LLC
$195
Boehringer Ingelheim Pharmaceuticals, Inc.
$147
AstraZeneca Pharmaceuticals LP
$134
Aurinia Pharma U.S., Inc.
$92
Radius Health, Inc.
$86
SOBI, INC
$79
GENZYME CORPORATION
$36
Corcept Therapeutics
$28
Alexion Pharmaceuticals, Inc.
$25
IBSA Pharma Inc.
$24
Kiniksa Pharmaceuticals International, plc
$21
Organon Llc
$20
Sandoz Inc.
$19
Novo Nordisk Inc
$17
Teva Pharmaceuticals USA, Inc.
$15
Top 3 companies account for 35.6% of 2024 payments
All-time payments by company (2018-2024) ›
Amgen Inc.
$4,439
Novartis Pharmaceuticals Corporation
$1,913
PFIZER INC.
$1,724
UCB, Inc.
$1,555
GlaxoSmithKline, LLC.
$1,545
ABBVIE INC.
$1,424
E.R. Squibb & Sons, L.L.C.
$1,345
Janssen Biotech, Inc.
$1,227
Lilly USA, LLC
$1,164
Mallinckrodt Hospital Products Inc.
$1,076
GENZYME CORPORATION
$972
Radius Health, Inc.
$850
AbbVie Inc.
$833
Boehringer Ingelheim Pharmaceuticals, Inc.
$712
AbbVie, Inc.
$639
Horizon Therapeutics plc
$500
Genentech USA, Inc.
$432
AstraZeneca Pharmaceuticals LP
$367
Fresenius Kabi USA, LLC
$333
Horizon Pharma plc
$320
Sobi, Inc
$234
SOBI, INC
$218
Antares Pharma, Inc.
$215
Alexion Pharmaceuticals, Inc.
$139
Dexcom, Inc.
$124
Janssen Scientific Affairs, LLC
$124
Mallinckrodt Enterprises LLC
$123
United Therapeutics Corporation
$113
Aurinia Pharma U.S., Inc.
$92
Mallinckrodt LLC
$68
Takeda Pharmaceuticals U.S.A., Inc.
$66
Sandoz Inc.
$52
Hikma Pharmaceuticals USA
$36
Celgene Corporation
$35
Teva Pharmaceuticals USA, Inc.
$35
Flexion Therapeutics, Inc.
$34
Corcept Therapeutics
$28
Exeltis, USA Inc.
$27
IBSA Pharma Inc.
$24
Tandem Diabetes Care, Inc.
$22
Kiniksa Pharmaceuticals International, plc
$21
Organon Llc
$20
West-Ward Pharmaceuticals
$17
Egalet US Inc
$17
Novo Nordisk Inc
$17
Abbott Laboratories
$17
Merck Sharp & Dohme Corporation
$15
Boston Scientific Corporation
$14
Avion Pharmaceuticals
$11
MEDEXUS PHARMA, INC.
$11
Top 3 companies account for 31.9% of all-time payments
Associated products mentioned in payments ›
ACTHAR · AMJEVITA · Actemra · Arcalyst · BENLYSTA · Balcoltra · Bimzelx · COSENTYX · CYLTEZO · Cimzia · Dexcom G6 Transmitter · EVENITY · EVUSHELD · Enbrel · FORTEO · FREESTYLE LIBRE 2 · HADLIMA · HUMIRA · HYRIMOZ · Humira · IDACIO · INFLECTRA · KEVZARA · KINERET · KRYSTEXXA · Kineret · Korlym · LUPKYNIS · LYRICA · Mitigare · NONE · OCTAGAM IMMUNE GLOBULIN (HUMAN) · OFEV · ORENCIA · OTREXUP · Otezla · Otrexup · PENNSAID · PRIMARY CARE - DISEASE STATE · PURIFIED CORTROPHIN GEL · Prolia · RAYOS · REMICADE · RENFLEXIS · RINVOQ · Rasuvo · Rinvoq · Rituxan · SAPHNELO · SIMPONI · SIMPONI ARIA · SKYRIZI · SPRIX · STELARA · STRENSIQ · Strensiq · TALTZ · TAVNEOS · TREMFYA · Tavneos · Tirosint · Truxima · Tyenne · Tymlos · Uloric · WATCHMAN · Wegovy · XELJANZ · Zilretta · t:slim X2 Insulin Pump with Control-IQ
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Rheumatologists in nearby ZIP areas
50
County median income
$70,293
Nearest hospital to ZIP centroid (approximate)
MEASE DUNEDIN HOSPITAL
5.0 mi
5.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Nagibina is a mixed practice specialist, with moderate Medicare volume, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Nagibina experienced with denosumab injection (prolia/xgeva)?
Based on Medicare claims data, Dr. Nagibina performed 3,960 denosumab injection (prolia/xgeva) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Nagibina receive payments from pharmaceutical companies?
Yes. Dr. Nagibina received a total of $25,340 from 50 companies across 1,423 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Nagibina's costs compare to other rheumatologists in Palm Harbor?
Dr. Nagibina's average Medicare payment per service is $28. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Nagibina) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Rheumatologists in Palm Harbor
Browse rheumatologists in Palm Harbor ranked by procedure volume and transparency data.
Highest volume
Top Rheumatologists in FL
Rheumatologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Rheumatologists in FL
Which FL rheumatologists receive the most from drug and device companies.
By company
Amgen Inc. Payments to Doctors
See all physicians who received payments from Amgen Inc.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
By company
PFIZER INC. Payments to Doctors
See all physicians who received payments from PFIZER INC.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology